Nutrien Ltd (NYSE:NTR) has been given an average rating of “Buy” by the nineteen research firms that are presently covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation, eleven have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $62.31.
NTR has been the subject of several research analyst reports. Royal Bank of Canada set a $65.00 price target on shares of Nutrien and gave the stock a “buy” rating in a research note on Tuesday, October 2nd. Macquarie lifted their price objective on shares of Nutrien from $59.00 to $66.00 and gave the company an “outperform” rating in a research note on Friday, October 12th. BMO Capital Markets upgraded shares of Nutrien from a “market perform” rating to an “outperform” rating in a research note on Tuesday, January 8th. Credit Suisse Group set a $55.00 price objective on shares of Nutrien and gave the company a “hold” rating in a research note on Wednesday, November 7th. Finally, TD Securities upgraded shares of Nutrien from a “hold” rating to a “buy” rating and lifted their price objective for the company from $63.00 to $68.00 in a research note on Wednesday, November 7th. They noted that the move was a valuation call.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Glassman Wealth Services grew its position in shares of Nutrien by 91.7% during the 3rd quarter. Glassman Wealth Services now owns 2,153 shares of the company’s stock valued at $124,000 after purchasing an additional 1,030 shares in the last quarter. FNY Investment Advisers LLC grew its position in shares of Nutrien by 4,210.3% during the 3rd quarter. FNY Investment Advisers LLC now owns 2,500 shares of the company’s stock valued at $144,000 after purchasing an additional 2,442 shares in the last quarter. Capital Advisors Ltd. LLC purchased a new position in shares of Nutrien during the 3rd quarter valued at $147,000. Dorsey & Whitney Trust CO LLC bought a new stake in shares of Nutrien during the 3rd quarter worth $204,000. Finally, Ipswich Investment Management Co. Inc. bought a new stake in shares of Nutrien during the 3rd quarter worth $206,000. Hedge funds and other institutional investors own 66.64% of the company’s stock.
Shares of Nutrien stock traded up $0.29 during mid-day trading on Tuesday, hitting $51.29. 1,297,952 shares of the stock were exchanged, compared to its average volume of 1,363,714. Nutrien has a 12 month low of $40.41 and a 12 month high of $58.99.
Nutrien (NYSE:NTR) last issued its quarterly earnings results on Monday, November 5th. The company reported $0.47 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.44 by $0.03. Nutrien had a net margin of 1.74% and a return on equity of 12.95%. The company had revenue of $4.03 billion during the quarter, compared to analyst estimates of $3.83 billion. The company’s revenue was up 226.9% on a year-over-year basis. As a group, sell-side analysts expect that Nutrien will post 2.64 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 18th. Investors of record on Friday, March 29th will be paid a $0.43 dividend. The ex-dividend date of this dividend is Thursday, March 28th. This represents a $1.72 dividend on an annualized basis and a yield of 3.35%.
Nutrien Ltd. produces and markets crop nutrients worldwide. The company offers potash, nitrogen, phosphate, and solid and liquid phosphate fertilizers; and phosphate feed, ammonium sulfate, and industrial acid products. It also retails seeds, crop protection and crop nutrient products, merchandise products, and agronomic services through operating 1,500 retail locations.
Further Reading: What is the quiet period?
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.